Levetiracetam use in critically ill patients

Author： Szaflarski Jerzy   Meckler Jason   Szaflarski Magdalena   Shutter Lori   Privitera Michael   Yates Stephen  

Publisher： Humana Press, Inc

ISSN： 1541-6933

Source： Neurocritical Care, Vol.7, Iss.2, 2007-10, pp. : 140-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Levetiracetam for Critically Ill Patients with Seizures

By Nau Karen  

Neurocritical Care, Vol. 11, Iss. 1, 2009-08 ,pp. : 34-37

Humana Press, Inc

Access to resources Recommend Favorite

Clopidogrel in Critically Ill Patients

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

What’s new in antimicrobial use and resistance in critically ill patients?

By Bassetti Matteo   Nicolau David   Calandra Thierry  

Intensive Care Medicine, Vol. 40, Iss. 3, 2014-03 ,pp. : 422-426

Springer Publishing Company

Access to resources Recommend Favorite

Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 774-779

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initial experience of use of tolvaptan in critically ill patients with fluid overload

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 339-341

John Wiley & Sons Inc

Access to resources Recommend Favorite